Security National Trust’s Gyre Therapeutics GYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-62
Closed -$3K 402
2020
Q4
$3K Buy
+62
New +$2.69K ﹤0.01% 394

Other funds holding GYRE

Security National Trust's GYRE Position: Q1 2021 in Review

Security National Trust sold out of Gyre Therapeutics (GYRE) in Q1 2021, closing a stake of 62 shares — an estimated $3K sold.

Security National Trust first reported a position in GYRE in Q4 2020 and held it in 1 quarter. The position peaked at $3K in Q4 2020. 89 funds tracked by Wall St. Rank hold GYRE as of Q1 2021.

  • Security National Trust reported no remaining Gyre Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Security National Trust sold 62 Gyre Therapeutics shares in Q1 2021, an estimated $3K.
  • Security National Trust first reported a position in Gyre Therapeutics in Q4 2020 and held it in 1 quarter.
  • Security National Trust's Gyre Therapeutics position peaked at $3K in Q4 2020.
  • 89 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q1 2021.

Based on Security National Trust's 13F filing for Q1 2021, filed 4 May 2021.